Theranica
Ivan Gergel serves as the Chairman of the Board of Directors at Corsair Pharma and holds directorial roles at Theranica Bio-Electronics Ltd., Butterfly Medical, and Neuraptive Therapeutics. As a Managing Partner and Chief Medical Officer at New Rhein Healthcare Investors, significant leadership is demonstrated across various healthcare organizations. Previous directorships include positions at Travecta Therapeutics, Neurotrope Inc., Realm Therapeutics, and Corium. Gergel has extensive experience in medical and business leadership, bolstered by a Doctor of Medicine degree from the University of London, MRCPsych from the Royal College of Psychiatrists, and an MBA from The Wharton School.
This person is not in the org chart
This person is not in any offices
Theranica
Theranica brings electrical neuromodulation therapy to a new level. They have developed Nerivio, a fully-integrated and self-contained family of therapeutic devices suited to be worn everywhere and at any time. The devices are operated by an attractive and easy-to-use smartphone application.